MMP14 and cancer: PARK7 is a substrate of matrix metalloproteinase (MMP)14, such as LGALS1, which is a potential therapeutic anti-cancer target and is cleaved at more than two sites by MMP1, MMP2, MMP8, MMP9, and MMP14.